Alkermes (ALKS) Profit After Tax (2010 - 2026)
Alkermes (ALKS) posted quarterly Profit After Tax of $501000.0 for Q2 2026, down 99.43% year-over-year from $87.2 million in Q2 2025, and up 100.75% quarter-over-quarter from -$66.5 million in Q1 2026.
Alkermes (ALKS) Profit After Tax (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has reported Profit After Tax for 17 consecutive years, with $501000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Profit After Tax fell 99.43% year-over-year to $501000.0; the TTM figure through Jun 2026 stood at $65.6 million (down 81.36% YoY), while the FY2025 annual figure was $241.7 million, down 35.06% from the prior year.
- Profit After Tax improved to $501000.0 in Q2 2026 per ALKS's latest filing, from -$66.5 million in the prior quarter.
- Across five years, Profit After Tax topped out at $237.1 million in Q2 2023 and bottomed at -$66.5 million in Q1 2026.
- Historically, Profit After Tax has averaged $46.3 million across 5 years, with a median of $42.6 million in 2024.
- Annual changes were most pronounced in 2022 — Profit After Tax sank 1374.79% — and 2023, when it jumped 886.65%.
- Alkermes' Profit After Tax stood at -$26.3 million in 2022, then surged by 710.32% to $160.6 million in 2023, then decreased by 9.23% to $145.7 million in 2024, then slumped by 66.77% to $48.4 million in 2025, then slumped by 98.97% to $501000.0 in 2026.
- Business Quant data shows ALKS's Profit After Tax at $501000.0 in Q2 2026, -$66.5 million in Q1 2026, and $48.4 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Alkermes | 8.14 Bn | 7.48 Bn | 397.90 Mn | 501,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 501,000.00 |
| Mar 31, 2026 | -66.48 Mn |
| Dec 31, 2025 | 48.43 Mn |
| Sep 30, 2025 | 83.10 Mn |
| Jun 30, 2025 | 87.15 Mn |
| Mar 31, 2025 | 22.46 Mn |
| Dec 31, 2024 | 145.74 Mn |
| Sep 30, 2024 | 96.40 Mn |
| Jun 30, 2024 | 91.36 Mn |
| Mar 31, 2024 | 36.83 Mn |
| Dec 31, 2023 | 160.55 Mn |
| Sep 30, 2023 | 91.55 Mn |
| Jun 30, 2023 | 237.07 Mn |
| Mar 31, 2023 | -41.85 Mn |
| Dec 31, 2022 | -26.31 Mn |
| Sep 30, 2022 | -66.32 Mn |
| Jun 30, 2022 | -30.14 Mn |
| Mar 31, 2022 | -35.90 Mn |
| Dec 31, 2021 | 126.57 Mn |
| Sep 30, 2021 | -29.24 Mn |